Jennifer R. Cochran

Jennifer R. Cochran (board member) discloses dealings in 2 companies, chiefly OmniAb, Inc. and Ligand Pharmaceuticals Inc. Over a trading history stretching from 12 July 2021 to 17 June 2026, the count stands at 14 filings.

Purchases make up the whole of the open-market record (3 purchases, €211k). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 5 share grants and 5 option exercises.

In size, the median ticket on the buying side is €80k. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The newest entry dates from 18 June 2026: an option exercise, in OmniAb, Inc. The last insider purchase was made public on 15 May 2025, 521 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.